Coherus Oncology
CHRS
CHRS
117 hedge funds and large institutions have $741M invested in Coherus Oncology in 2016 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 40 increasing their positions, 23 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
36% more funds holding
Funds holding: 86 → 117 (+31)
84% less call options, than puts
Call options by funds: $644K | Put options by funds: $3.99M
Holders
117
Holding in Top 10
2
Calls
$644K
Puts
$3.99M
Top Buyers
| 1 | +$22.3M | |
| 2 | +$18M | |
| 3 | +$16.2M | |
| 4 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$10.2M |
| 5 |
BM
Bridger Management
New York
|
+$9.64M |
Top Sellers
| 1 | -$15.8M | |
| 2 | -$14.9M | |
| 3 | -$8.18M | |
| 4 |
VMI
VHCP Management II
New York
|
-$3.47M |
| 5 |
Axa
Paris,
France
|
-$2.78M |